We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCTY icon
576
Paylocity
PCTY
$8.1B
$96.3M 0.02%
2,229,153
+2,023,813
+986% +$75.9M
BNCL
577
DELISTED
Beneficial Bancorp, Inc.
BNCL
$95.8M 0.02%
7,534,645
+273,270
+4% +$3.71M
TDS icon
578
Telephone and Data Systems
TDS
$4.03B
$95.4M 0.02%
3,217,529
-245,650
-7% -$7.07M
SHOP icon
579
Shopify
SHOP
$204B
$95.1M 0.02%
30,913,930
-2,040,360
-6% -$5.96M
P
580
Everpure Inc
P
$39B
$94.7M 0.02%
8,690,450
-432,320
-5% -$5.64M
RAD
581
DELISTED
Rite Aid Corporation
RAD
$94.7M 0.02%
632,132
-410,207
-39% -$64.7M
KMB icon
582
Kimberly-Clark
KMB
$36.8B
$94.3M 0.02%
686,210
+14,501
+2% +$1.9M
BVN icon
583
Compañía de Minas Buenaventura
BVN
$8.55B
$94.1M 0.02%
7,876,913
+1,140,370
+17% +$11M
ROIC
584
DELISTED
Retail Opportunity Investments Corp.
ROIC
$94M 0.02%
4,339,850
+617,280
+17% +$12.5M
ADBE icon
585
Adobe
ADBE
$108B
$93.9M 0.02%
980,221
+25,885
+3% +$2.49M
HSY icon
586
Hershey
HSY
$37.4B
$93.5M 0.02%
823,764
+56,272
+7% +$5.27M
GK
587
DELISTED
G&K Services Inc
GK
$93.3M 0.02%
1,217,880
-3,780
-0.3% -$278K
SCCO icon
588
Southern Copper
SCCO
$158B
$92.9M 0.02%
3,760,077
+834,136
+29% +$20.9M
SHO icon
589
Sunstone Hotel Investors
SHO
$2.02B
$92.8M 0.02%
7,684,519
+1,046,723
+16% +$13.1M
APH icon
590
Amphenol
APH
$204B
$92.6M 0.02%
6,461,536
-86,560
-1% -$1.24M
JNS
591
DELISTED
Janus Capital Group Inc
JNS
$92.2M 0.02%
6,620,880
-394,635
-6% -$5.78M
GPOR
592
DELISTED
Gulfport Energy Corp.
GPOR
$92.2M 0.02%
2,948,085
+1,137,807
+63% +$34.4M
MJN
593
DELISTED
Mead Johnson Nutrition Company
MJN
$92M 0.02%
1,013,659
+66,394
+7% +$5.62M
NORD
594
DELISTED
Nord Anglia Education, Inc.
NORD
$91.5M 0.02%
4,327,275
+1,240,204
+40% +$26.8M
RL icon
595
Ralph Lauren
RL
$23.1B
$91.5M 0.02%
1,020,465
+909,540
+820% +$84.5M
HLIO icon
596
Helios Technologies
HLIO
$2.67B
$90.4M 0.02%
3,046,260
+45,320
+2% +$1.43M
CLC
597
DELISTED
Clarcor
CLC
$90.3M 0.02%
1,485,086
-23,380
-2% -$1.37M
ISEE
598
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$90.2M 0.02%
1,767,562
-665
-0% -$33K
GD icon
599
General Dynamics
GD
$106B
$90M 0.02%
646,630
+111,763
+21% +$15.6M
EL icon
600
Estee Lauder
EL
$31.6B
$89.7M 0.02%
985,172
-419,827
-30% -$39.2M

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.